JP2005515191A - 創傷の治療及び使用する組成物 - Google Patents

創傷の治療及び使用する組成物 Download PDF

Info

Publication number
JP2005515191A
JP2005515191A JP2003546869A JP2003546869A JP2005515191A JP 2005515191 A JP2005515191 A JP 2005515191A JP 2003546869 A JP2003546869 A JP 2003546869A JP 2003546869 A JP2003546869 A JP 2003546869A JP 2005515191 A JP2005515191 A JP 2005515191A
Authority
JP
Japan
Prior art keywords
composition
wound
effective amount
pharmaceutically effective
ions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003546869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005515191A5 (enExample
Inventor
エイチ．、 モンロー、スティーヴン
フークシュテラ、ハンス
Original Assignee
グレイストーン メディカル グループ、インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by グレイストーン メディカル グループ、インコーポレイテッド filed Critical グレイストーン メディカル グループ、インコーポレイテッド
Publication of JP2005515191A publication Critical patent/JP2005515191A/ja
Publication of JP2005515191A5 publication Critical patent/JP2005515191A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003546869A 2001-11-29 2002-11-27 創傷の治療及び使用する組成物 Pending JP2005515191A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33433701P 2001-11-29 2001-11-29
PCT/US2002/038175 WO2003045366A1 (en) 2001-11-29 2002-11-27 Treatment of wounds and compositions employed

Publications (2)

Publication Number Publication Date
JP2005515191A true JP2005515191A (ja) 2005-05-26
JP2005515191A5 JP2005515191A5 (enExample) 2006-01-26

Family

ID=23306754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003546869A Pending JP2005515191A (ja) 2001-11-29 2002-11-27 創傷の治療及び使用する組成物

Country Status (8)

Country Link
US (5) US20030133991A1 (enExample)
EP (1) EP1461024A4 (enExample)
JP (1) JP2005515191A (enExample)
AU (1) AU2002359529B2 (enExample)
CA (1) CA2468390A1 (enExample)
MX (1) MXPA04005219A (enExample)
NZ (1) NZ533252A (enExample)
WO (1) WO2003045366A1 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014104064A1 (ja) * 2012-12-26 2014-07-03 株式会社エーゼット 創傷治癒促進剤
JP2014520657A (ja) * 2011-07-20 2014-08-25 スリーエム イノベイティブ プロパティズ カンパニー イオン担持組成物を含んだ包帯
JP2014521649A (ja) * 2011-07-28 2014-08-28 スリーエム イノベイティブ プロパティズ カンパニー 創傷治癒組成物及び使用方法
WO2016199907A1 (ja) * 2015-06-12 2016-12-15 Ｊｆｅミネラル株式会社 皮膚創傷または皮膚荒れ治療剤
WO2016199905A1 (ja) * 2015-06-12 2016-12-15 Ｊｆｅミネラル株式会社 皮膚創傷または皮膚荒れ治療剤
WO2018105739A1 (ja) * 2016-12-09 2018-06-14 Ｊｆｅミネラル株式会社 亜鉛イオン徐放性に優れる無機組成物およびその製造方法

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023937A1 (en) * 2002-05-24 2004-02-05 Greystone Medical Group, Inc. Anti-cancer formulation
JP2006511585A (ja) * 2002-12-23 2006-04-06 グレイストーン メディカル グループ、インコーポレイテッド 慢性創傷管理における活性酸素種の減少
US20050175715A1 (en) * 2003-08-25 2005-08-11 Monroe Stephen H. Cellular depolarization and regulation of matrix metalloproteinases
WO2006002326A2 (en) * 2004-06-22 2006-01-05 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
US20070212342A1 (en) * 2005-12-20 2007-09-13 Swiss-American Products, Inc. Protease compositions for the treatment of damaged tissue
US8795730B2 (en) * 2006-01-31 2014-08-05 David John Vachon Compositions and methods for promoting the healing of tissue of multicellular organisms
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
PL1993569T3 (pl) 2006-02-03 2014-11-28 Obagi Cosmeceuticals Llc Terapia przeciw starzeniu z użyciem kompozycji miedzi i cynku
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
WO2007143586A2 (en) * 2006-06-01 2007-12-13 Pharmaionx, Inc. Composition for wound care and method of using same
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
EP2152359A2 (en) 2007-05-25 2010-02-17 Compex Medical S.A. Wound healing electrode set
ITBS20070178A1 (it) * 2007-11-15 2009-05-16 Paoli Ambrosi Gianfranco De Composizione per uso farmaceutico e/o cosmetico e/o in forma di dispositivo medico per favorire processi di cicatrizzazione, per il trattamento di cicatrici ipertrofiche e per migliorare le proprieta' biomeccaniche della cute
US20100260863A1 (en) * 2007-12-11 2010-10-14 Monroe Stephen H Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110008271A1 (en) * 2009-07-13 2011-01-13 Jr Chem, Llc Rosacea treatments using polymetal complexes
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
GB201116523D0 (en) * 2011-09-23 2011-11-09 Systagenix Wound Man Ip Co Bv Wound prognosis
EP2896963B1 (en) 2011-01-31 2019-01-30 Woundchek Laboratories B.V. Wound prognosis
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
RU2636523C1 (ru) * 2017-02-09 2017-11-23 федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ВГМУ им. Н.Н. Бурденко Минздрава России) Лекарственное средство для ускорения заживления ран, содержащее хлорид рубидия в виде порошка
CN116631510B (zh) * 2022-10-28 2024-01-12 中国人民解放军军事科学院军事医学研究院 一种用于鉴别诊断克罗恩病和溃疡性结肠炎的装置
WO2024196897A1 (en) * 2023-03-22 2024-09-26 Courtland Imel Novel methods for increasing healing speed of human and animal wounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08503462A (ja) * 1992-11-06 1996-04-16 エイチ・イー・スタンリー・ファーマシューティカルズ・インコーポレイテッド オーク樹皮抽出物の組成物、関連する合成組成物およびこれを用いる方法
WO2000054593A1 (en) * 1999-03-12 2000-09-21 Bristol-Myers Squibb Company Iodine preparation compositon
WO2001082896A1 (en) * 2000-04-28 2001-11-08 Biolife, L.L.C Hemostatic agent, method and carrier for applying a blood clotting agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600711A (en) * 1982-08-18 1986-07-15 The University Of Kentucky Research Foundation Composition for topical and infusion treatment of wounds and burns
DE3416777C2 (de) * 1984-05-07 1986-11-20 Gödecke AG, 1000 Berlin Pharmazeutische topische Zubereitungen
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20020141964A1 (en) * 2001-01-19 2002-10-03 Patterson James A. Composition for arresting the flow of blood and method
US6600057B2 (en) * 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08503462A (ja) * 1992-11-06 1996-04-16 エイチ・イー・スタンリー・ファーマシューティカルズ・インコーポレイテッド オーク樹皮抽出物の組成物、関連する合成組成物およびこれを用いる方法
WO2000054593A1 (en) * 1999-03-12 2000-09-21 Bristol-Myers Squibb Company Iodine preparation compositon
WO2001082896A1 (en) * 2000-04-28 2001-11-08 Biolife, L.L.C Hemostatic agent, method and carrier for applying a blood clotting agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6009029844, 医薬品添加物事典, 1994, 第１版, 第３８−３９頁 *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014520657A (ja) * 2011-07-20 2014-08-25 スリーエム イノベイティブ プロパティズ カンパニー イオン担持組成物を含んだ包帯
JP2014521649A (ja) * 2011-07-28 2014-08-28 スリーエム イノベイティブ プロパティズ カンパニー 創傷治癒組成物及び使用方法
JPWO2014104064A1 (ja) * 2012-12-26 2017-01-12 株式会社エーゼット 創傷治癒促進剤
US9962364B2 (en) 2012-12-26 2018-05-08 A-Z Ltd. Wound healing accelerator
WO2014104064A1 (ja) * 2012-12-26 2014-07-03 株式会社エーゼット 創傷治癒促進剤
JPWO2016199907A1 (ja) * 2015-06-12 2018-03-29 Ｊｆｅミネラル株式会社 皮膚創傷または皮膚荒れ治療剤
JPWO2016199905A1 (ja) * 2015-06-12 2017-06-22 Ｊｆｅミネラル株式会社 皮膚創傷または皮膚荒れ治療剤
KR20170142205A (ko) * 2015-06-12 2017-12-27 제이에프이미네라르 가부시키가이샤 피부 창상 또는 피부 거침 치료제
WO2016199905A1 (ja) * 2015-06-12 2016-12-15 Ｊｆｅミネラル株式会社 皮膚創傷または皮膚荒れ治療剤
WO2016199907A1 (ja) * 2015-06-12 2016-12-15 Ｊｆｅミネラル株式会社 皮膚創傷または皮膚荒れ治療剤
KR101889677B1 (ko) * 2015-06-12 2018-08-17 제이에프이미네라르 가부시키가이샤 피부 창상 또는 피부 거침 치료제
US10780114B2 (en) 2015-06-12 2020-09-22 Jfe Mineral Company, Ltd. Therapeutic agent for skin wound or rough skin
US11020427B2 (en) 2015-06-12 2021-06-01 Jfe Mineral Company, Ltd. Therapeutic agent for skin wound or rough skin
WO2018105739A1 (ja) * 2016-12-09 2018-06-14 Ｊｆｅミネラル株式会社 亜鉛イオン徐放性に優れる無機組成物およびその製造方法
JPWO2018105739A1 (ja) * 2016-12-09 2019-10-24 Ｊｆｅミネラル株式会社 亜鉛イオン徐放性に優れる無機組成物およびその製造方法
US10987380B2 (en) 2016-12-09 2021-04-27 Jfe Mineral Company, Ltd. Hydrozincite containing zinc carbonate hydroxide hydrate and method of making

Also Published As

Publication number Publication date
CA2468390A1 (en) 2003-06-05
MXPA04005219A (es) 2005-06-20
EP1461024A4 (en) 2009-03-25
US20070298121A1 (en) 2007-12-27
US20100196507A1 (en) 2010-08-05
EP1461024A1 (en) 2004-09-29
AU2002359529A1 (en) 2003-06-10
US20070009611A1 (en) 2007-01-11
WO2003045366A1 (en) 2003-06-05
AU2002359529B2 (en) 2008-02-21
US20030133991A1 (en) 2003-07-17
US20060029682A1 (en) 2006-02-09
NZ533252A (en) 2006-03-31

Similar Documents

Publication Publication Date Title
JP2005515191A (ja) 創傷の治療及び使用する組成物
EP3308793B1 (en) Therapeutic agent for skin wound or rough skin
US20070190178A1 (en) Composition and method for the therapeutic modulation of matrix metalloproteinase
JP6970980B2 (ja) 慢性創傷の壊死組織除去法
CN102105177B (zh) 治疗皮肤损伤的药物组合物、敷料和方法,用于制备所述敷料的中间组合物和方法,以及与胶原基质缔合的铈盐的用途
US20240285735A1 (en) Methods of debridement of chronic wounds
CA3012299C (en) Debriding composition for treating wounds
HK1150785B (en) Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051125

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090619

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090918

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091005

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091016

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091027

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091118

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091126

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100413